In this Grand Round meet the recipients of the inaugural small translation research grants. Launched last year by the Clinical Research Incubator, this funding initiative aimed to empower 10 RCH clinicians who were new to research, including nurses, doctors, and allied health professionals.
Both RSV and Dengue have proved to be difficult vaccine targets. In both cases vaccine development has taken a very long time, and in both cases some vaccine candidates have led to more severe disease in some individuals. We are currently in the middle of an era of remarkable progress in both fields, but problems remain.
In today’s Grand Round Dr Tom Forbes will discuss primary hyperoxaluria (PH), an ultra-rare and often devastating kidney-stone forming disease which can lead to recurrent kidney stones and end-stage kidney disease.
This Grand Round will provide a critical overview of what we know about holding children for clinical procedures, considering the child, parent, health professional and system factors which can influence procedural practice. Lucy will discuss an approach to challenge accepted narratives within practice and adopt a more child-centred rights-based approach to reduce harm and the use of restrictive practice during procedures.
One hundred years ago the first insulin injection was given at RCH. Overnight, type 1 diabetes went from a fatal to a ‘manageable’ condition. Since that time, diabetes management has developed and evolved to a point where in the near future it is hoped that exogenous insulin will represent a treatment failure rather than a therapeutic mainstay. This Grand Round will trace the history of insulin therapy and diabetes management at RCH, and discuss the likely direction of new therapies in the upcoming decades.
The approach and attitude towards Functional Neurological Disorders (FND) has changed over the last decade and anecdotally at least, we seem to be seeing more cases in our day-to-day practice. Patients with functional symptoms present to many disciplines and functional symptoms can co-exist with organic pathology. There is now evidence to show earlier diagnosis and treatment can lead to more positive outcomes.
After completing a comprehensive process, including stakeholder engagement and workshops, the Murdoch Children’s Research Institute has established a Cancer Flagship to bring together child health researchers across multiple disciplines interested and invested in childhood cancer across the research continuum.
The Grand Rounds will explore:
Bringing the voice of the child and family into our day-to-day interactions, and the importance of lived experience perspectives when designing new approaches to support mental health and wellbeing.
The independent Consultative Council on Obstetric and Paediatric Mortality and Morbidity (CCOPMM) reviews cases of maternal, perinatal, and paediatric mortality and morbidity. Child deaths have been reviewed since 1985. The child and adolescent subcommittee of CCOPMM reviews deaths and develops recommendations and good practice points for practitioners and health systems.
Multi-disciplinary care is vital for the treatment of complex patients, especially those with rare diseases. The benefits of multi-disciplinary collaboration go beyond clinical outcomes and include research.
